Announced Thu, 30 Apr · 18:15 IST

Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2026 ,inter alia, to consider and approve Audited Results and Audit Report

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹3.83
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0-0.8-2.3-3.4-3.7-3.7-5.7-10.7-1.3
Up moveDown movePending
AI summary

Natural Biocon (India) Ltd has informed BSE that its Board Meeting, originally scheduled for April 30, 2026, has been postponed and rescheduled to May 9, 2026. The meeting will consider and approve the Audited Financial Results along with the Auditor's Report for the quarter and year ended March 31, 2026. The company will also consider the Certificate for unmodified opinion from the auditors. This is a procedural rescheduling notice under SEBI LODR Regulation 29.

Likely market impact

This is a routine administrative filing indicating a one-week delay in board approval of annual results. No direct impact on shareholders at this stage; investors should await the actual results announcement on or after May 9, 2026.